Mould and bird nests: FDA finds unapproved biologics at Sanofi plants
This article was originally published in Scrip
Executive Summary
The FDA has raised multiple concerns in a warning letter to Sanofi Pasteur following inspections of its plants in Marcy l'Etoile, France, and Toronto earlier this year.